The blockbuster weight-loss drugs Wegovy and Ozempic have helped many patients rapidly slim down. But these powerful pharmaceuticals could have unintended consequences we may not be ready for. Meanwhile, what motivates people to wear masks? Post COVID, researchers are finally beginning to find some answers.
Join host Cameron English, Dr. Chuck Dinerstein and Dr. Barbara Billauer as they break down these stories on Episode 58 of the Science Dispatch podcast:
The weight loss drugs Wegovy and Ozempic portend a massive impact on the “obesity epidemic.” Users may even be able to get insurance coverage, as the FDA just approved a third drug specifically for weight loss treatment, signaling greater coverage for all drugs in the class. Sounds promising, right? But, alas, there are unintended consequences.
This is a bit of a rhetorical question. It's based on the simple fact that the percentage of the population wearing a mask in public in July 2022 was; 86% in Japan; 43% in the U.S.; 21% in the U.K., and 5% in Denmark. Japan was not alone among the Asian nations, all wearing masks in the 80% or greater range. Why might that be?
Listen to the Science Dispatch on iTunes Spotify, Stitcher and Google Podcasts. Or add the RSS feed to your favorite podcast app. Join our Dispatch newsletter to get these stories and more delivered to your inbox.
